Hypnodoc
0806.055.746 · rovalta.com · 22/09/2026
NORMAL SITUATION
Hypnodoc
Financial year 2025 · closed on 19/09/2025
Net result
4,4 k €
+168.4% YoY
Gross margin
4,4 k €
+240.3% YoY
Equity
-56,8 k €
-161.6% YoY
Company — Normal situation.
Overview
What does Hypnodoc do?
Hypnodoc is a company registered in Belgium.
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0806.055.746
Legal form
Private limited company
Contributed capital
12 400,00 €
Latest accounts
19/09/2025
Signals
ProfitablePositive cashflowPositive EBITDA
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||
| Gross margin | 4,4 k € | +240% | -3,1 k € | +65.5% | -9 k € | +54.2% | -19,7 k € | +24.9% | -26,2 k € | -157% | 46 k € | -30.1% | 65,8 k € | +10.7% | 59,4 k € | +11.0% | 53,5 k € | -39.1% | 87,9 k € | +0.3% | 87,6 k € | -16.9% | 105,5 k € | -31.8% | 154,6 k € | +40.3% | 110,3 k € | +40.5% | 78,5 k € | -5.5% | 83 k € | -39.0% | 136,1 k € |
| EBITDA | 3,7 k € | +189% | -4,1 k € | +57.7% | -9,8 k € | +52.4% | -20,6 k € | +24.0% | -27,1 k € | -161% | 44,7 k € | -31.1% | 64,8 k € | +11.0% | 58,4 k € | +12.9% | 51,7 k € | -40.1% | 86,3 k € | +1.4% | 85,1 k € | -18.1% | 103,9 k € | -31.9% | 152,6 k € | +40.6% | 108,5 k € | +41.6% | 76,6 k € | -3.4% | 79,3 k € | -40.6% | 133,6 k € |
| Operating result | 3,7 k € | +157% | -6,5 k € | +46.6% | -12,2 k € | +48.3% | -23,5 k € | +21.7% | -30 k € | -170% | 43,2 k € | -33.4% | 64,8 k € | +11.0% | 58,4 k € | +14.7% | 50,9 k € | -40.0% | 84,8 k € | +1.8% | 83,4 k € | -6.6% | 89,2 k € | -35.8% | 138,9 k € | +45.3% | 95,6 k € | +51.2% | 63,2 k € | +8.8% | 58,1 k € | -55.1% | 129,5 k € |
| Net result | 4,4 k € | +168% | -6,5 k € | +50.6% | -13,1 k € | +45.0% | -23,8 k € | +22.4% | -30,6 k € | -206% | 29 k € | -33.7% | 43,7 k € | +3.2% | 42,4 k € | +38.8% | 30,5 k € | -42.5% | 53,1 k € | -0.9% | 53,6 k € | -6.8% | 57,5 k € | -37.3% | 91,7 k € | +52.5% | 60,1 k € | +114% | 28,1 k € | -36.2% | 44 k € | -49.4% | 87 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||
| Equity | -56,8 k € | -162% | 92,3 k € | -6.6% | 98,7 k € | -40.1% | 164,9 k € | -12.6% | 188,7 k € | -14.0% | 219,3 k € | +15.2% | 190,3 k € | +29.8% | 146,6 k € | +40.6% | 104,2 k € | +41.4% | 73,7 k € | +257% | 20,7 k € | -65.6% | 60,1 k € | -68.3% | 189,3 k € | +93.9% | 97,6 k € | -2.6% | 100,2 k € | +39.0% | 72,1 k € | -27.5% | 99,4 k € |
| Total assets | 89 k € | -3.7% | 92,4 k € | -39.4% | 152,5 k € | -7.7% | 165,1 k € | -12.5% | 188,8 k € | -16.5% | 226,1 k € | +17.0% | 193,2 k € | +24.9% | 154,7 k € | +35.8% | 113,9 k € | +43.3% | 79,5 k € | -7.2% | 85,7 k € | -66.5% | 255,9 k € | +32.0% | 193,8 k € | +60.4% | 120,9 k € | -3.2% | 124,8 k € | -0.3% | 125,2 k € | +6.5% | 117,6 k € |
| Cash | 88,7 k € | +3.7% | 85,5 k € | -42.5% | 148,8 k € | -6.6% | 159,3 k € | -2.7% | 163,6 k € | -26.3% | 222,1 k € | +26.1% | 176,2 k € | +34.7% | 130,8 k € | +25.6% | 104,2 k € | +33.2% | 78,2 k € | -4.4% | 81,9 k € | -66.6% | 245,4 k € | +37.2% | 178,8 k € | +86.0% | 96,1 k € | +18.7% | 81 k € | +89.7% | 42,7 k € | -58.1% | 101,8 k € |
| Debts | 145,6 k € | +98784% | 147,3 € | -99.7% | 53,7 k € | +23633% | 226,5 € | +73.9% | 130,2 € | -98.1% | 6,8 k € | +136% | 2,9 k € | -64.4% | 8,1 k € | -16.2% | 9,7 k € | +67.3% | 5,8 k € | -91.1% | 65 k € | -66.8% | 195,8 k € | +4248% | 4,5 k € | -80.6% | 23,2 k € | -5.7% | 24,6 k € | -53.6% | 53,1 k € | +193% | 18,2 k € |
Governance
Board of directors
Seen on filing of 19/09/2025 · 1 active · 1 ended
Active mandates
Emmy VAN DE STEEN
ActiveEnded mandates
Emmy Van De Steen
EndedFinancials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 19/09/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 9 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 24/04/2026 | 20/06/2025 | 24/06/2024 | 28/08/2023 | 30/06/2022 | 24/06/2021 |
| General meeting | 19/09/2025 | 18/06/2025 | 21/06/2024 | 22/08/2023 | 17/06/2022 | 18/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
17 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 19/09/2025 | 19/09/2025 | 24/04/2026 | Dutch | |
| Micro model | 31/12/2024 | 18/06/2025 | 20/06/2025 | Dutch | |
| Micro model | 31/12/2023 | 21/06/2024 | 24/06/2024 | Dutch | |
| Micro model | 31/12/2022 | 22/08/2023 | 28/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 17/06/2022 | 30/06/2022 | Dutch | |
| Micro model | 31/12/2020 | 18/06/2021 | 24/06/2021 | Dutch | |
| Micro model | 31/12/2019 | 19/06/2020 | 06/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 21/06/2019 | 11/07/2019 | Dutch | |
| Micro model | 31/12/2017 | 15/06/2018 | 29/06/2018 | Dutch | |
| Micro model | 31/12/2016 | 16/06/2017 | 30/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 17/06/2016 | 30/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 19/06/2015 | 09/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 20/06/2014 | 26/06/2014 | Dutch | |
| Abridged model | 31/12/2012 | 21/06/2013 | 17/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 15/06/2012 | 29/06/2012 | Dutch | |
| Abridged model | 31/12/2010 | 17/06/2011 | 08/07/2011 | Dutch | |
| Abridged model | 31/12/2009 | 18/06/2010 | 28/06/2010 | Dutch |
Valuation
Estimate
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 19/09/2025 · 1 active · 1 ended
Active mandates
Emmy VAN DE STEEN
ActiveEnded mandates
Emmy Van De Steen
EndedShareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20254,4 k €↑
- 2025Name changeHypnodoc in vereffening
- 2024Annual accounts 2024-6,5 k €↑
- 2023Annual accounts 2023-13,1 k €↑
- 2022Annual accounts 2022-23,8 k €↑
- 2022Name changeHypnodoc
- 2021Annual accounts 2021-30,6 k €↓
- 2021Name changeDokter Van De Steen
- 2020Annual accounts 202029 k €↓
- 2019Annual accounts 201943,7 k €↑
- 2018Annual accounts 201842,4 k €↑
- 2017Annual accounts 201730,5 k €↓
- 2016Annual accounts 201653,1 k €↓
- 2015Annual accounts 201553,6 k €↓
- 2014Annual accounts 201457,5 k €↓
- 2013Annual accounts 201391,7 k €↑
- 2012Annual accounts 201260,1 k €↑
- 2011Annual accounts 201128,1 k €↓
- 2010Annual accounts 201044 k €↓
- 2009Annual accounts 200987 k €